Literature DB >> 344810

A prospective study of enteropathogenic Escherichia coli in endemic diarrheal disease.

M Gurwith, D Hinde, R Gross, B Rowe.   

Abstract

The rate of isolation of Escherichia coli belonging to the traditional serotypes enteropathogenic for infants was studied prospectively in two groups. Group 1 consisted of children with diarrhea and of controls without gastrointestinal disease who were matched for age and inpatient or outpatient status. Group 2 consisted of families entered in a prospective study of rotavirus infections. In group 1 enteropathogenic Escherichia coli were found in 13 (6%) of 220 children younger than 12 months of age and in nine (6%) of 143 children 12--35 months of age, all of whom had diarrhea. Enteropathogenic E. coli were found in only one of an equal number of matched controls (P = 0.002 and 0.004, respectively). In group 2 enteropathogenic E. coli were present in seven (18%) of 38 specimens obtained during diarrheal episodes, as compared with five (1%) of 492 specimens obtained when there was no diarrhea (P less than 0.001). The enteropathogenic E. coli isolated were not enterotoxigenic. The most common serogroup was O111, but many different O:H serotypes were detected. Thus, the association of enteropathogenic E. coli with endemic diarrhea was significant, even though no enteropathogenic mechanism was apparent.

Entities:  

Mesh:

Year:  1978        PMID: 344810     DOI: 10.1093/infdis/137.3.292

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.

Authors:  M S Donnenberg; C O Tacket; G Losonsky; G Frankel; J P Nataro; G Dougan; M M Levine
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

2.  Enteropathogenecity of Escherichia coli.

Authors:  E Neter
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Enterotoxin production, presence of colonization factor antigen I, and adherence to HeLa cells by Escherichia coli O128 strains belonging to different O subgroups.

Authors:  B E Guth; L M Silva; I C Scaletsky; M R Toledo; L R Trabulsi
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

4.  Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties.

Authors:  L C Campos; T S Whittam; T A Gomes; J R Andrade; L R Trabulsi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose.

Authors:  D J Evans; D G Evans; H L DuPont
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  Enteropathogen carriage by healthy individuals living in an area with poor sanitation.

Authors:  G Figueroa; M Troncoso; M Araya; J Espinoza; O Brunser
Journal:  J Hyg (Lond)       Date:  1983-12

Review 7.  Adhesion and its role in the virulence of enteropathogenic Escherichia coli.

Authors:  D Law
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

8.  Enteropathogenic Escherichia coli serotypes and endemic diarrhea in infants.

Authors:  M R Toledo; M do C Alvariza; J Murahovschi; S R Ramos; L R Trabulsi
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Serotype, antimicrobial resistance, and adherence properties of Escherichia coli strains associated with outbreaks of diarrheal illness in children in the United States.

Authors:  M Moyenuddin; I K Wachsmuth; S L Moseley; C A Bopp; P A Blake
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.